Does point-of-care testing save money or cost more?

Laboratory Medicine

Volumn 36, Issue 8, 2005, Pages 465-467

  Hortin, Glen L ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SAMPLING; BLOOD VOLUME; BUDGET; COST BENEFIT ANALYSIS; COST CONTROL; HEALTH CARE MANPOWER; HEALTH CARE QUALITY; LABORATORY TEST; POINT OF CARE TEST; RESOURCE MANAGEMENT; SHORT SURVEY;

EID: 23044466536     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJ9D0GHYYWEDYHPD     Document Type: Short Survey

References (18)

1. Hughes M. Market trends in point-of-care testing. Point of Care. 2002;1:84-94.
2. Paxton A. Labs waver on whether to bill for POC tests. CAP Today. 2001;15:1.
3. MacMillan D. Reimbursement for point-of-care testing. Point of Care. 2002;4:253-258.
4. Menzin J, Langley-Hawthorne C, Friedman M, et al. Potential short-term economic benefits of improved glycemic control: A managed care perspective. Diabet Care. 2001;24:51-55.
5. Winter WE, Harris NS. Self-monitoring of blood glucose: Needless expense or a vital glycemic monitor? Point of Care. 2003;2:62-68.
6. DeCresce RP, Phillips DL, Howanitz PJ. Financial justification of alternate site testing. Arch Pathol Lab Med. 1995;119:898-901.
7. Keffer JH. Economic consideration of point-of-care testing. Am J Clin Pathol. 1995;104(Suppl 1):S107-S110.
8. Lee-Lewandrowski E, Laposata M, Eschenbach K, et al. Utilization and cost analysis of bedside capillary glucose testing in a large teaching hospital: implications for managing point of care testing. Am J Med. 1994;97:222-230.
9. Winkelman JW, Wybenga DR, Tansijevic MJ. The fiscal consequences of central vs distributed testing of glucose. Clin Chem. 1994;40:1628-1630.
10. Howanitz PJ, Jones BA. Comparative analytical costs of a central laboratory glucose and bedside glucose testing: A College of American Pathologists Q-Probes study. Arch Pathol Lab Med. 2004;128:739-745.
11. Moultrie CA, Hortin GL, Randolph VR. Comparative costs and labor efficiency of bedside versus central laboratory glucose testing [absract]. Clin Chem. 1997;43:S162.
12. Boone DJ, Hay JW, Aguanno J, et al. Are the correct economic factors influencing point-of-care testing. Point of Care. 2002:1:212-221.
13. Hortin GL. Management of point-of-care testing. In Clinical Laboratory Management, L Garcia, VS Baselski, MD Burke, et al, editors, Washington, DC: American Society of Microbiology; 2004: 404-416.
14. Novis DA, Walsh MK, Dale JC, et al. Continuous monitoring of stat and routine outlier turnaround times. Two College of American Pathologists Q-Tracks monitors in 291 hospitals. Arch Pathol Lab Med. 2004;128:621-626.
15. nd edition, CP Price, A St. John, JM Hicks, editors, Washington DC: AACC Press; 2004:109-115.
16. Van den Berghe G. Tight blood glucose control with insulin in "real-life" intensive care. Mayo Clin Proc. 2004;79:977-978.
17. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79:992-1000.
18. Kilgore ML, Steindel SJ, Smith JA. Cost analysis for decision support: the case of comparing centralized versus distributed methods for blood gas testing. J Healthcare Manag. 1999;44:207-215.